The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
Anastasiou, D., Poulogiannis, G., Asara, J. M., Boxer, M. B., Jiang, J.-K., Shen, M., Bellinger, G., Sasaki, A. T., Locasale, J. W., Auld, D. S., et al. (2011) · Science · doi:10.1126/science.1211485 · Cited by 1,190
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Yang, W., Xia, Y., Ji, H., Zheng, Y., Liang, J., Huang, W., Gao, X., Aldape, K., & Lu, Z. (2011) · Nature · doi:10.1038/nature10598 · Cited by 1,028
Acetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux
Wang, Q., Zhang, Y., Yang, C., Xiong, H., Lin, Y., Yao, J., Li, H., Xie, L., Zhao, W., Yao, Y., et al. (2010) · Science · doi:10.1126/science.1179687 · Cited by 1,008
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995
Pyruvate kinase type M2 and its role in tumor growth and spreading
Mazurek, S., Boschek, C. B., Hugo, F., & Eigenbrodt, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.009 · Cited by 812
Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth
Hitosugi, T., Kang, S., Vander Heiden, M. G., Chung, T.-W., Elf, S., Lythgoe, K., Dong, S., Lonial, S., Wang, X., Chen, G. Z., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000431 · Cited by 784
Pyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein Kinase
Gao, X., Wang, H., Yang, J. J., Liu, X., & Liu, Z.-R. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.001 · Cited by 772
Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
Mazurek, S. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.02.005 · Cited by 694
Lv, L., Li, D., Zhao, D., Lin, R., Chu, Y., Zhang, H., Zha, Z., Liu, Y., Li, Z., Xu, Y., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.025 · Cited by 610
Sun, Q., Chen, X., Ma, J., Peng, H., Wang, F., Zha, X., Wang, Y., Jing, Y., Yang, H., Chen, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014769108 · Cited by 586
Noguchi, T., Inoue, H., & Tanaka, T. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67091-7 · Cited by 537
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
Chen, J., Xie, J., Jiang, Z., Wang, B., Wang, Y., & Hu, X. (2011) · Oncogene · doi:10.1038/onc.2011.137 · Cited by 512
Akt-dependent transformation: there is more to growth than just surviving
Plas, D. R., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1209097 · Cited by 429
Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review
Porporato, P. E., Dhup, S., Dadhich, R. K., Copetti, T., & Sonveaux, P. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00049 · Cited by 425
Clower, C. V., Chatterjee, D., Wang, Z., Cantley, L. C., Vander Heiden, M. G., & Krainer, A. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914845107 · Cited by 424
Structural Basis for Tumor Pyruvate Kinase M2 Allosteric Regulation and Catalysis,
Dombrauckas, J. D., Santarsiero, B. D., & Mesecar, A. D. (2005) · Biochemistry · doi:10.1021/bi0474923 · Cited by 409
Multimolecular Forms of Pyruvate Kinase from Rat and Other Mammalian Tissues*
IMAMURA, K., & TANAKA, T. (1972) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a129852 · Cited by 360
Noguchi, T., Yamada, K., Inoue, H., Matsuda, T., & Tanaka, T. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47947-1 · Cited by 333
Mitochondria in cancer: Not just innocent bystanders
Frezza, C., & Gottlieb, E. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.008 · Cited by 268
Self-citationNo evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
Bluemlein, K., Grüning, N.-M., Feichtinger, R. G., Lehrach, H., Kofler, B., & Ralser, M. (2011) · Oncotarget · doi:10.18632/oncotarget.278 · Cited by 253
Identification of small molecule inhibitors of pyruvate kinase M2
Vander Heiden, M. G., Christofk, H. R., Schuman, E., Subtelny, A. O., Sharfi, H., Harlow, E. E., Xian, J., & Cantley, L. C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.003 · Cited by 237
Chen, M., Zhang, J., & Manley, J. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2513 · Cited by 236
Modulation of type M 2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein
Zwerschke, W., Mazurek, S., Massimi, P., Banks, L., Eigenbrodt, E., & Jansen-Dürr, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1291 · Cited by 223
Pyruvate Kinase Triggers a Metabolic Feedback Loop that Controls Redox Metabolism in Respiring Cells
Grüning, N.-M., Rinnerthaler, M., Bluemlein, K., Mülleder, M., Wamelink, M. M. C., Lehrach, H., Jakobs, C., Breitenbach, M., & Ralser, M. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.017 · Cited by 217
Lee, J., Kim, H. K., Han, Y.-M., & Kim, J. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.009 · Cited by 214
Nutrient and hormonal regulation of pyruvate kinase gene expression
YAMADA, K., & NOGUCHI, T. (1999) · Biochemical Journal · doi:10.1042/bj3370001 · Cited by 185
Nuclear Translocation of the Tumor Marker Pyruvate Kinase M2 Induces Programmed Cell Death
Steták, A., Veress, R., Ovádi, J., Csermely, P., Kéri, G., & Ullrich, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2870 · Cited by 183
Ashizawa, K., Willingham, M. C., Liang, C. M., & Cheng, S. Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55378-3 · Cited by 172
The Role of Phosphometabolites in Cell Proliferation, Energy Metabolism, and Tumor Therapy
Mazurek, S., Boschek, C. B., & EIGENBRODT, E. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022490512705 · Cited by 172
Discher, D. J., Bishopric, N. H., Wu, X., Peterson, C. A., & Webster, K. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26087 · Cited by 166
Boxer, M. B., Jiang, J., Heiden, M. G. V., Shen, M., Skoumbourdis, A. P., Southall, N. T., Veith, H., Leister, W., Austin, C. P., Park, H. W., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901577g · Cited by 165
Inborn and acquired metabolic defects in cancer
Frezza, C., Pollard, P. J., & Gottlieb, E. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0728-4 · Cited by 155
Self-citationMazurek, S., Zwerschke, W., Jansen‐Dürr, P., & EIGENBRODT, E. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3560247 · Cited by 147
Jiang, J., Boxer, M. B., Heiden, M. G. V., Shen, M., Skoumbourdis, A. P., Southall, N. T., Veith, H., Leister, W., Austin, C. P., Park, H. W., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.015 · Cited by 131
Mazurek, S., Zwerschke, W., Jansen‐Dürr, P., & EIGENBRODT, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204792 · Cited by 122
Bailey, E., Stirpe, F., & Taylor, C. B. (1968) · Biochemical Journal · doi:10.1042/bj1080427 · Cited by 115
Boles, E., Schulte, F., Miosga, T., Freidel, K., Schlüter, E., Zimmermann, F. K., Hollenberg, C. P., & Heinisch, J. J. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.9.2987-2993.1997 · Cited by 113
Cytosolic thyroid hormone-binding protein is a monomer of pyruvate kinase.
Kato, H., Fukuda, T., Parkison, C., McPhie, P., & Cheng, S.-Y. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7861 · Cited by 99
Regulation of Cell Proliferation by Interleukin-3-induced Nuclear Translocation of Pyruvate Kinase
Hoshino, A., Hirst, J. A., & Fujii, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700094200 · Cited by 96
Hacker, H. J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.99 · Cited by 81
Spoden, G. A., Mazurek, S., Morandell, D., Bacher, N., Ausserlechner, M. J., Jansen‐Dürr, P., EIGENBRODT, E., & Zwerschke, W. (2008) · International Journal of Cancer · doi:10.1002/ijc.23512 · Cited by 80
Presek, P., Reinacher, M., & EIGENBRODT, E. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81014-7 · Cited by 78
L- and M2- pyruvate kinase expression in renal cell carcinomas and their metastases
Brinck, U., Fischer, G., EIGENBRODT, E., Oehmke, M. J., & Mazurek, S. (1994) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00193498 · Cited by 77
The SUMO‐E3 ligase PIAS3 targets pyruvate kinase M2
Spoden, G. A., Morandell, D., Ehehalt, D., Fiedler, M., Jansen‐Dürr, P., Hermann, M., & Zwerschke, W. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22125 · Cited by 77
Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas.
EIGENBRODT, E., Basenau, D., Holthusen, S., Mazurek, S., & Fischer, G. (1997) · PubMed · Cited by 71
Purification of four pyruvate kinase isozymes of rats by affinity elution chromatography
Harada, K., Saheki, S., Wada, K., & Tanaka, T. (1978) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(78)90169-9 · Cited by 70
Walsh, M. J., Brimacombe, K. R., Veith, H., Bougie, J. M., Daniel, T. O., Leister, W., Cantley, L. C., Israelsen, W. J., Heiden, M. G. V., Shen, M., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.114 · Cited by 66
Hathurusinghe, H. R., Goonetilleke, K. S., & Siriwardena, A. K. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9481-x · Cited by 64
Expression of pyruvate kinase M 2 in preneoplastic hepatic foci of N -nitrosomorpholine-treated rats
Steinberg, P., Klingelhöffer, A., Schäfer, A., Wüst, G., Weisse, G., Oesch, F., & EIGENBRODT, E. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050330 · Cited by 60
Cerwenka, H., Aigner, R., Bacher, H., Werkgartner, G., El-Shabrawi, A., Quehenberger, F., & Mischinger, H. J. (1999) · PubMed · Cited by 55
The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma.
Oremek, G. M., Teigelkamp, S., Kramer, W., et al. (1999) · PubMed · Cited by 54
Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism.
Mazurek, S., Drexler, H. C. A., Troppmair, J., EIGENBRODT, E., & Rapp, U. R. (2007) · PubMed · Cited by 53
Nutrient and hormonal regulation of pyruvate kinase gene expression
Yamada, K., & Noguchi, T. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3370001 · Cited by 46
Expression of L- and M-type pyruvate kinase in human tissues
Tsutsumi, H., Tani, K., Fujii, H., & Miwa, S. (1988) · Genomics · doi:10.1016/0888-7543(88)90112-7 · Cited by 44
Studies on associations of glycolytic and glutaminolytic enzymes in MCF-7 cells: Role of P36
Mazurek, S., Hugo, F., Failing, K., & EIGENBRODT, E. (1996) · Journal of Cellular Physiology · Cited by 37
EIGENBRODT, E., Leib, S. L., Krămer, W., Friis, R. R., & Schöner, W. (1983) · PubMed · Cited by 32
Koss, K., Harrison, R. F., Gregory, J., Darnton, S. J., Anderson, M., & Jankowski, J. A. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.018150 · Cited by 31
Insulin Stimulates Expression of the Pyruvate Kinase M Gene in 3T3-L1 Adipocytes
Asai, Y., Yamada, K., Watanabe, T., Keng, V. W., & Noguchi, T. (2003) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.67.1272 · Cited by 18
Cited by
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova-Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,141
Serine is a natural ligand and allosteric activator of pyruvate kinase M2
Chaneton, B., Hillmann, P., Zheng, L., Martin, A. C. L., Maddocks, O. D. K., Chokkathukalam, A., Coyle, J. E., Jankevics, A., Holding, F. P., Vousden, K. H., et al. (2012) · Nature · doi:10.1038/nature11540 · Cited by 661
Self-citationMYC, Metabolism, Cell Growth, and Tumorigenesis
Dang, C. V. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014217 · Cited by 602
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells
Israelsen, W. J., Dayton, T. L., Davidson, S. M., Fiske, B. P., Hosios, A. M., Bellinger, G., Li, J., Yu, Y., Sasaki, M., Horner, J. W., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.025 · Cited by 549
“The M2 isoform of pyruvate kinase (PKM2) is preferentially expressed in cancer, where complex regulation of its activity is important for control of cell metabolism (Chaneton and Gottlieb, 2012; Mazurek, 2011).”
Cordes, T., Wallace, M., Michelucci, A., Divakaruni, A. S., Sapcariu, S. C., Sousa, C., Koseki, H., Cabrales, P., Murphy, A. N., Hiller, K., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.685792 · Cited by 526
Metadata
- Authors
- Chaneton, B., & Gottlieb, E.
- Venue
- Trends in Biochemical Sciences
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 37
- Issue
- 8
- Pages
- 309-316
- ISSN
- 0968-0004 (ISSN-L)
- OpenAlex
- W1993350172
- Cited by
- 294
- References
- 62
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.